Paul B. Dressler, MD, MPH
Autism Spectrum Disorder, Developmental Disability, Intellectual Disability, Developmental Delays
Autism Spectrum Disorder, Developmental Disability, Intellectual Disability, Developmental Delays
Drs. Dana Janssen, Thomas Doyle, and George Nicholson founded Influent Medical, LLC, a biomedical startup with a mission of developing devices for congenital heart disease.
Interventional pediatric cardiology
Specialty
Cardiology, Pediatric
M.D.
University of Arizona School of Medicine, 1987
Internship
Pediatric Internship-University of Maryland, Baltimore, MD
Residency
Pediatric Residency-University of Maryland, Baltimore, MD
Fellowship
Pediatric Cardiology Fellowship-Yale University School of Medicine, New Haven, CT
Dr. Tom Doub joined Vanderbilt Health Center for Patient and Professional Advocacy (CPPA) after more than 20 years working to integrate research and practice across a variety of behavioral health leadership positions, and is excited to apply those lessons to CPPA’s mission.
Prior to joining CPPA in 2019, he served as Chief Clinical Officer and Chief Compliance Officer at American Addiction Centers (AAC), where he was responsible for national oversight of clinical, quality, and compliance programs for one of the nation’s largest providers of addiction treatment. Previously, he was Chief Executive Officer of Centerstone Research Institute (CRI), a not-for-profit organization dedicated to improving healthcare through research and information technology. Dr. Doub joined Centerstone as Vice President of Research in 2003. He was named Chief Operating Officer of CRI in 2008 and appointed CEO in 2011. Under Dr. Doub’s leadership, CRI established a unique blend of research, technology and evaluation services, pursuing a vision where all individuals and families facing behavioral health disorders receive exceptional care. The organization was awarded more than $150 million in grant funding, established influential partnerships with prominent universities and researchers across the nation and was involved in more than 150 groundbreaking studies. CRI innovators built tools such as Enlighten Analytics, an innovative analytics platform that transforms operational and clinical data into functional, insightful information to help improve operations, reduce costs and enhance patient care.
Dr. Doub and CRI’s team of more than 100 experienced researchers, analysts, statisticians and technology professionals received broad recognition for their successful and impactful integration of research and technology, including being featured in IBM’s Smarter Planet Leadership Series, winning the Data Warehousing Institute’s Best Practices Award in 2010, SAMHSA’s Science and Service Award and the National Council for Community Behavioral Healthcare’s Innovation Award. Dr. Doub also has been honored as a Healthcare Hero by the Nashville Business Journal. Dr. Doub is regularly invited to share his expertise with diverse groups including IBM’s Information-On-Demand conference, and other national meetings.
Dr. Doub received his Ph.D. in both Clinical and Quantitative Psychology from Vanderbilt University. He serves as a thought leader in behavioral health and technology throughout a number of social media platforms, sharing industry perspective, breakthroughs, and innovations in behavioral health and technology.
Ph.D.
Clinical and Quantitative Psychology - Vanderbilt University
Dr. Stacy Dorris’ research focuses on food allergies. Vanderbilt’s Food Allergy Program is a Food Allergy Research and Education (FARE) Center of Excellence. As director of the Food Allergy Program, she manages a long-term national registry of fatal food reactions and is the principal investigator for a study with DBV involving the peanut patch in allergic children age 1-3 years old.
Specialty
Allergy, Pediatric
M.D.
Vanderbilt University School of Medicine, Nashville, TN
Residency
Pediatrics - Vanderbilt University Medical Center, Nashville, TN
Fellowship
Allergy/Immunology - Vanderbilt University Medical Center, Nashville, TN
Gastrointestinal Disorders, Inflammatory Bowel Disease, Polyposis disorders, Hereditary Colorectal Cancer
Specialty
Gastroenterology, Pediatric
M.D.
Medical University of South Carolina, 2011
Residency
Pediatric Residency-University of Tennessee Health Science Center, Le Bonheur Children's Hospital, Memphis TN, 2014
Fellowship
Pediatric Gastroenterology, Hepatology and Nutrition Fellowship - Vanderbilt University School of Medicine, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN, 2018
M.D.
University of Puerto Rico School of Medicine
Residency
Pediatrics - Baylor College of Medicine/Texas Children's and Affiliated Hospitals
Fellowships
Pediatric Critical Care Medicine Fellowship - Vanderbilt University Medical Center/Monroe Carell Jr. Children's Hospital at Vanderbilt
Senior Fellowship in Pediatric Cardiac Intensive Care - Baylor College of Medicine/Texas Children's and Affiliated Hospitals
We are focused on social determinants of successful transition to adult care for youth living with HIV. We conduct IRB approved longitudinal research on youth living with HIV in our multidisciplinary Adolescent and Young Adult Health Care Transition Clinic.
Adolescent HIV, Transition to Adult Care
Specialty
Adolescent Medicine
MD
University of Tennessee, College of Medicine, Memphis, TN, 2002
Internship
Internship, Internal Medicine and Pediatrics-University of Tennessee, Memphis, TN
Residency
Residency, Internal Medicine and Pediatrics-University of Tennessee, Memphis, TN
Congenital Heart Disease, Cardiac Embryology
Specialty
Cardiology, Pediatric
M.D.
Case Western Reserve University School of Medicine, Cleveland, OH, 1991
Internship
Internship -Vanderbilt University Hospital, Nashville, TN
Residency
Residency -Vanderbilt University Hospital, Nashville, TN
Fellowship
Fellowship -Vanderbilt University Hospital, Nashville, TN
Developmental delay, Autism spectrum disorder, Behavior concerns, ADHD consultation
Specialty
Developmental Medicine, Pediatric
M.S.N.
Nursing - Pediatric Primary Care, Vanderbilt University, Nashville, Tennessee
Dr. DeBaun is an internationally recognized physician-scientist whose advocacy and research have resulted in fundamental advances in medical care of children and adults with sickle cell disease (SCD) and children with Beckwith Wiedemann Syndrome, a cancer predisposition syndrome. He is Professor of Pediatrics and Medicine, Vice Chair of Clinical and Translational Research in the Department of Pediatrics and holds the JC Peterson Endowed Chair at Vanderbilt University School of Medicine. After receiving his degrees from Stanford, he completed his pediatric residency, served as chief resident, and completed his pediatric hematology-oncology fellowship at St. Louis Children's Hospital, Washington University School of Medicine. He then completed a four-year United States Public Health Service Epidemiology fellowship at the National Institutes of Health (NIH). During the fellowship he obtained an MPH degree from Johns Hopkins Bloomberg School of Public Health (2003). Dr. DeBaun returned to St. Louis and spent 14 years at Washington University School of Medicine where he was promoted to Professor of Pediatrics, Biostatistics, and Neurology, and was the inaugural Ferring Family Chair in Pediatrics. He also received the following Washington University Medical School Awards: Humanism in Medicine Award (2002), Clinical Teacher of the Year Award (2008), and Distinguished Faculty Award (2009). In 2010, Dr. DeBaun was recruited to Vanderbilt University School of Medicine where he founded the Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease. The Center is one of the first in the country to establish a medical home care model for children and adults with SCD in a community health center. For over two decades, Dr. DeBaun has received continuous funding from the National Institute of Health (NIH) and Robert Wood Johnson, Doris Duke and Burroughs Wellcome foundations. Dr. DeBaun was the primary physician author of the Sickle Cell Treatment Act, signed by President Bush into law on Oct. 22, 2004 Title VII, creating regional networks for enhanced services for with SCD. His research efforts in SCD have focused on the clinical epidemiology of acute and chronic lung disease, sequelae of silent and overt strokes, including leading eight investigator-initiated controlled stroke trials in North America, Europe, and Africa. Additionally, in Ghana, he was the leader of multi-disciplinary team decreasing the death rate of pregnant women with SCD by approximately 90% and continues to work with the team at Korle Bu Teaching Hospital. His research has expanded to include the clinical history and optimal therapy for recurrent ischemic priapism in men with sickle cell disease living in Nigeria and malnutrition in older children with sickle cell disease living in Nigeria. Dr. DeBaun is an elected member of the American Society of Clinical Investigation (2006), Association of American Physicians (2008) and National Academy of Medicine (2009). He has received the Ernest Beutler Prize and Lecture in Clinical Science from the American Society of Hematology (2014) and two international mentor awards for his work in Ghana, Nigeria and U.S.: the Maureen Andrews Mentor Award from the Society of Pediatric Research (2017) and the American Society of Hematology Mentor Award (2019).
Sickle cell disease
Specialty
Hematology/Oncology, Pediatric
M.D.
Stanford University School of Medicine, Stanford, CA, 1987
M.S.
Stanford University School of Medicine, Stanford, CA, 1987
M.P.H.
The Johns Hopkins University School of Hygiene and Public Health, Baltimore, MD, 1993
Residencies
Pediatric Residency-Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, MO
Pediatric Chief Resident-Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, MO
Fellowships
Pediatric Hematology/Oncology Fellowship-Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, MO
Epidemiology Fellowship-United States Public Health Service, National Cancer Institute, National Institutes of Health, Bethesda, MD